This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodford, N.
Right arrow Articles by Speller, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodford, N.
Right arrow Articles by Speller, D. C.

 Previous Article

Clinical Microbiology Reviews, 10 1995, 585-615, Vol 8, No. 4
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Current perspectives on glycopeptide resistance

N Woodford, AP Johnson, D Morrison and DC Speller
Antibiotic Reference Unit, Central Public Health Laboratory, London, England.

In the last 5 years, clinical isolates of gram-positive bacteria with intrinsic or acquired resistance to glycopeptide antibiotics have been encountered increasingly. In many of these isolates, resistance arises from an alteration of the antibiotic target site, with the terminal D- alanyl-D-alanine moiety of peptidoglycan precursors being replaced by groups that do not bind glycopeptides. Although the criteria for defining resistance have been revised frequently, the reliable detection of low-level glycopeptide resistance remains problematic and is influenced by the method chosen. Glycopeptide-resistant enterococci have emerged as a particular problem in hospitals, where in addition to sporadic cases, clusters of infections with evidence of interpatient spread have occurred. Studies using molecular typing methods have implicated colonization of patients, staff carriage, and environmental contamination in the dissemination of these bacteria. Choice of antimicrobial therapy for infections caused by glycopeptide-resistant bacteria may be complicated by resistance to other antibiotics. Severe therapeutic difficulties are being encountered among patients infected with enterococci, with some infections being untreatable with currently available antibiotics.


This article has been cited by other articles:

  • San Millan, A., Depardieu, F., Godreuil, S., Courvalin, P. (2009). VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to Vancomycin. Antimicrob. Agents Chemother. 53: 1974-1982 [Abstract] [Full Text]  
  • Brown, D. F. J., Hope, R., Livermore, D. M., Brick, G., Broughton, K., George, R. C., Reynolds, R., on behalf of the BSAC Working Parties on Resistanc, (2008). Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 62: ii75-ii85 [Abstract] [Full Text]  
  • Brown, D. F. J., Edwards, D. I., Hawkey, P. M., Morrison, D., Ridgway, G. L., Towner, K. J., Wren, M. W. D., on behalf of the Joint Working Party of the Britis, (2005). Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56: 1000-1018 [Abstract] [Full Text]  
  • Depardieu, F., Perichon, B., Courvalin, P. (2004). Detection of the van Alphabet and Identification of Enterococci and Staphylococci at the Species Level by Multiplex PCR. J. Clin. Microbiol. 42: 5857-5860 [Abstract] [Full Text]  
  • Bustamante, W., Alpizar, A., Hernandez, S., Pacheco, A., Vargas, N., Herrera, M. L., Vargas, A., Caballero, M., Garcia, F. (2003). Predominance of vanA Genotype among Vancomycin-Resistant Enterococcus Isolates from Poultry and Swine in Costa Rica. Appl. Environ. Microbiol. 69: 7414-7419 [Abstract] [Full Text]  
  • Jureen, R., Top, J., Mohn, S. C., Harthug, S., Langeland, N., Willems, R. J. L. (2003). Molecular Characterization of Ampicillin-Resistant Enterococcus faecium Isolates from Hospitalized Patients in Norway. J. Clin. Microbiol. 41: 2330-2336 [Abstract] [Full Text]  
  • Johnson, A. P., Woodford, N. (2002). Glycopeptide-resistant Staphylococcus aureus. J Antimicrob Chemother 50: 621-623 [Full Text]  
  • Giacometti, A., Cirioni, O., Ghiselli, R., Orlando, F., Mocchegiani, F., Riva, A., Del Prete, M. S., Saba, V., Scalise, G. (2002). Efficacy of Quinupristin-Dalfopristin in Preventing Vascular Graft Infection Due to Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides. Antimicrob. Agents Chemother. 46: 2885-2888 [Abstract] [Full Text]  
  • Ligozzi, M., Bernini, C., Bonora, M. G., de Fatima, M., Zuliani, J., Fontana, R. (2002). Evaluation of the VITEK 2 System for Identification and Antimicrobial Susceptibility Testing of Medically Relevant Gram-Positive Cocci. J. Clin. Microbiol. 40: 1681-1686 [Abstract] [Full Text]  
  • Recktenwald, J., Shawky, R., Puk, O., Pfennig, F., Keller, U., Wohlleben, W., Pelzer, S. (2002). Nonribosomal biosynthesis of vancomycin-type antibiotics: a heptapeptide backbone and eight peptide synthetase modules. Microbiology 148: 1105-1118 [Abstract] [Full Text]  
  • MIYAZAKI, S., FUJIKAWA, T., KOBAYASHI, I., MATSUMOTO, T., TATEDA, K., YAMAGUCHI, K. (2001). Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J Med Microbiol 50: 695-701 [Abstract] [Full Text]  
  • Cetinkaya, Y., Falk, P., Mayhall, C. G. (2000). Vancomycin-Resistant Enterococci. Clin. Microbiol. Rev. 13: 686-707 [Abstract] [Full Text]  
  • Johnson, A. P., Warner, M., Hallas, G., Livermore, D. M. (2000). Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. J Antimicrob Chemother 46: 125-128 [Abstract] [Full Text]  
  • Hussain, Z., Stoakes, L., Garrow, S., Longo, S., Fitzgerald, V., Lannigan, R. (2000). Rapid Detection of mecA-Positive and mecA-Negative Coagulase-Negative Staphylococci by an Anti-Penicillin Binding Protein 2a Slide Latex Agglutination Test. J. Clin. Microbiol. 38: 2051-2054 [Abstract] [Full Text]  
  • Zeckel, M. L., Preston, D. A., Allen, B. S. (2000). In Vitro Activities of LY333328 and Comparative Agents against Nosocomial Gram-Positive Pathogens Collected in a 1997 Global Surveillance Study. Antimicrob. Agents Chemother. 44: 1370-1374 [Abstract] [Full Text]  
  • Shibata, K., Nagano, R., Hashizume, T., Morishima, H. (2000). Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1{beta}-methylcarbapenem, against experimental murine systemic infections. J Antimicrob Chemother 45: 379-382 [Abstract] [Full Text]  
  • Roberts, G., Tarelli, E., Homer, K. A., Philpott-Howard, J., Beighton, D. (2000). Production of an Endo-beta -N-Acetylglucosaminidase Activity Mediates Growth of Enterococcus faecalis on a High-Mannose-Type Glycoprotein. J. Bacteriol. 182: 882-890 [Abstract] [Full Text]  
  • Hussain, Z., Stoakes, L., Massey, V., Diagre, D., Fitzgerald, V., El Sayed, S., Lannigan, R. (2000). Correlation of Oxacillin MIC with mecA Gene Carriage in Coagulase-Negative Staphylococci. J. Clin. Microbiol. 38: 752-754 [Abstract] [Full Text]  
  • Ke, D., Picard, F. J., Martineau, F., Ménard, C., Roy, P. H., Ouellette, M., Bergeron, M. G. (1999). Development of a PCR Assay for Rapid Detection of Enterococci. J. Clin. Microbiol. 37: 3497-3503 [Abstract] [Full Text]  
  • Candiani, G., Abbondi, M., Borgonovi, M., Romano, G., Parenti, F. (1999). In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic. J Antimicrob Chemother 44: 179-192 [Abstract] [Full Text]  
  • Ieven, M., Vercauteren, E., Descheemaeker, P., van Laer, F., Goossens, H. (1999). Comparison of Direct Plating and Broth Enrichment Culture for the Detection of Intestinal Colonization by Glycopeptide-Resistant Enterococci among Hospitalized Patients. J. Clin. Microbiol. 37: 1436-1440 [Abstract] [Full Text]  
  • Morrison, D., Woodford, N., Barrett, S. P., Sisson, P., Cookson, B. D. (1999). DNA Banding Pattern Polymorphism in Vancomycin-Resistant Enterococcus faecium and Criteria for Defining Strains. J. Clin. Microbiol. 37: 1084-1091 [Abstract] [Full Text]  
  • Lefort, A., Baptista, M., Fantin, B., Depardieu, F., Arthur, M., Carbon, C., Courvalin, P. (1999). Two-Step Acquisition of Resistance to the Teicoplanin-Gentamicin Combination by VanB-Type Enterococcus faecalis In Vitro and in Experimental Endocarditis. Antimicrob. Agents Chemother. 43: 476-482 [Abstract] [Full Text]  
  • Zelenitsky, S. A., Booker, B., Laing, N., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G. (1999). Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother. 43: 592-597 [Abstract] [Full Text]  
  • Tremlett, C. H., Brown, D. F. J., Woodford, N. (1999). Variation in Structure and Location of VanA Glycopeptide Resistance Elements among Enterococci from a Single Patient. J. Clin. Microbiol. 37: 818-820 [Abstract] [Full Text]  
  • (1999). Tackling antimicrobial resistance. DTB 37: 9-16 [Abstract] [Full Text]  
  • Baltch, A. L., Smith, R. P., Ritz, W. J., Bopp, L. H. (1998). Comparison of Inhibitory and Bactericidal Activities and Postantibiotic Effects of LY333328 and Ampicillin Used Singly and in Combination against Vancomycin-Resistant Enterococcus faecium. Antimicrob. Agents Chemother. 42: 2564-2568 [Abstract] [Full Text]  
  • Chen, Y.-S., Marshall, S. A., Winokur, P. L., Coffman, S. L., Wilke, W. W., Murray, P. R., Spiegel, C. A., Pfaller, M. A., Doern, G. V., Jones, R. N. (1998). Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci. J. Clin. Microbiol. 36: 2996-3001 [Abstract] [Full Text]  
  • Ligozzi, M., Lo Cascio, G., Fontana, R. (1998). vanA Gene Cluster in a Vancomycin-Resistant Clinical Isolate of Bacillus circulans. Antimicrob. Agents Chemother. 42: 2055-2059 [Abstract] [Full Text]  
  • Bell, J. M., Paton, J. C., Turnidge, J. (1998). Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates. J. Clin. Microbiol. 36: 2187-2190 [Abstract] [Full Text]  
  • Liassine, N., Frei, R., Jan, I., Auckenthaler, R. (1998). Characterization of Glycopeptide-Resistant Enterococci from a Swiss Hospital. J. Clin. Microbiol. 36: 1853-1858 [Abstract] [Full Text]  
  • Bascomb, S., Manafi, M. (1998). Use of Enzyme Tests in Characterization and Identification of Aerobic and Facultatively Anaerobic Gram-Positive Cocci. Clin. Microbiol. Rev. 11: 318-340 [Abstract] [Full Text]  
  • Woodford, N., Adebiyi, A.-M. A., Palepou, M.-F. I., Cookson, B. D. (1998). Diversity of VanA Glycopeptide Resistance Elements in Enterococci from Humans and Nonhuman Sources. Antimicrob. Agents Chemother. 42: 502-508 [Abstract] [Full Text]  
  • Sieradzki, K., Villari, P., Tomasz, A. (1998). Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of Staphylococci. Antimicrob. Agents Chemother. 42: 100-107 [Abstract] [Full Text]  
  • Pratt, S. D., Xuei, X., Mackinnon, A. C., Nilius, A. M., Hensey-Rudloff, D. M., Zhong, P., Katz, L. (1997). Development of a Coupled VanA/VanX Assay: Screening for Inhibitors of Glycopeptide Resistance. J Biomol Screen 2: 241-247 [Abstract]  
  • Jones, D. B. (1996). Emerging Antibiotic Resistance: Real and Relative. Arch Ophthalmol 114: 91-92 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»